CollPlant Biotechnologies (CLGN) Acquisitions (2020 - 2021)
CollPlant Biotechnologies (CLGN) posted Acquisitions of $8.3 million for Q3 2021, up 469.36% on a QoQ basis from -$2.2 million in Q2 2021, and up 506.3% year-over-year from $1.4 million in Q3 2020.
CollPlant Biotechnologies (CLGN) Acquisitions (2020 - 2021) Analysis & Trends
CollPlant Biotechnologies' Acquisitions history runs 2 years deep, the most recent figure standing at $8.3 million for Q3 2021.
- Quarterly Acquisitions rose 506.3% year-over-year to $8.3 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $24.1 million (changed N/A YoY) and the FY2020 annual result came in at $3.3 million, down 12.08% from the prior year.
- Acquisitions was $8.3 million for Q3 2021 at CollPlant Biotechnologies, up from -$2.2 million in the prior quarter.
- Across five years, Acquisitions topped out at $19.7 million in Q1 2021 and bottomed at -$2.2 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 8.27 Mn |
| Jun 30, 2021 | -2.24 Mn |
| Mar 31, 2021 | 19.72 Mn |
| Dec 31, 2020 | -1.70 Mn |
| Sep 30, 2020 | 1.36 Mn |
| Jun 30, 2020 | -1.94 Mn |
| Mar 31, 2020 | 5.61 Mn |